Arca
Skip to content

SMO: Protein smoothened

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

G protein-coupled receptor, which transduces the smoothened signaling pathway.

  • Drugs that act on it: 8
  • With a US drug page: 3
  • Type: Protein

Drugs That Act on It

Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page
GlasdegibApprovedSmoothened homolog antagonistAntagonistBoxed warning
SonidegibApprovedSmoothened homolog inhibitorInhibitorBoxed warning
VismodegibApprovedSmoothened homolog inhibitorInhibitorBoxed warning
BMS-833923—Smoothened homolog antagonistAntagonist—
LEQ506—Smoothened homolog antagonistAntagonist—
Patidegib—Smoothened homolog antagonistAntagonist—
TAK-441—Smoothened homolog antagonistAntagonist—
Taladegib—Smoothened homolog antagonistAntagonist—

Diseases Most Associated With It

Open Targets association score, 0 to 1; all associations
Basal cell carcinoma
0.75
Curry-Jones syndrome
0.74
Congenital hypothalamic hamartoma syndrome
0.64
Neoplasm
0.53
Osteoarthritis, hip
0.48
Hirschsprung disease
0.46
Microcephaly
0.40
Skin basal cell carcinoma
0.39
Ameloblastoma
0.38

Drugs and mechanisms are from ChEMBL CHEMBL5971 (CC BY-SA 3.0). Gene name, function (UniProt Q99835, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.